HARBIN GLORIA PHARMACEUTICALS Co., LTD completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd.
October 27, 2023
Share
HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million on October 15, 2023. This has been approved in the 9th Meeting of the HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) 6th Directorate held on October 15, 2023, and does not need the Shareholders? Approval.
HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. on October 28, 2023.
HARBIN GLORIA PHARMACEUTICALS Co., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's products include cardiovascular and cerebrovascular drugs, orthopedic drugs, nutritional drugs, anti-infective drugs, immune-enhancing drugs, diabetes drugs, antineoplastic drugs and electrolytes drugs. The Company is also engaged in the agency, research and development of pharmaceuticals, the provision of clinical services and financial investment business. The Company distributes its products within domestic market and to overseas markets.